Executive Director, US Medical Affairs (USMA) Strategy – Liver and Covid at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalIndustries

Requirements

  • Experience with launch planning and external collaborations

Responsibilities

  • Develop and execute USMA Viral Hepatitis, PBC, and COVID-19 Plans of Action
  • Conduct landscape assessments of unmet medical needs and industry trends
  • Oversee and maintain Gilead’s US scientific communications related to Viral Hepatitis, PBC, and COVID-19
  • Develop high-quality medical affairs resources, medical presentations, and advisory boards
  • Engage with US providers and advocates
  • Collaborate with colleagues across Gilead to ensure alignment on strategic priorities

Skills

Key technologies and capabilities for this role

Medical Affairs StrategyScientific CommunicationsLandscape AssessmentAdvisory BoardsLaunch PlanningStakeholder EngagementCross-functional CollaborationViral HepatitisPrimary Biliary CholangitisCOVID-19

Questions & Answers

Common questions about this position

What is the salary for this Executive Director position?

This information is not specified in the job description.

Is this role remote or onsite?

The position is onsite.

What skills or experience are required for this role?

This information is not specified in the job description.

What is the company culture like at Gilead Sciences?

Gilead Sciences is dedicated to creating a healthier world by developing innovative medicines for diseases like HIV, viral hepatitis, primary biliary cholangitis, and cancers, operating in over 35 countries with a collaborative approach across functions.

How should I apply for this position at Gilead?

Current Gilead employees and contractors should log onto the Internal Career Site to apply.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI